The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Buprenorphine for Opioid Detoxification: A Brief Review
Abstract
Objectives To review the pharmacotherapy of opioid dependence focusing on detoxification using buprenorphine, a partial μ-opioid agonist. Methods Based on a literature review of recent studies, general approaches to the use of buprenorphine and the associated success are summarized. Results Like methadone, longer duration of buprenorphine stabilization and associated psychosocial treatment is associated with a better outcome and less relapse. However, a simple detoxification can be done by gradually reducing the dose of buprenorphine from a standard starting dose of 4–8 mg daily over a period of a week to as long as a month. When a transition to the antagonist naltrexone is desired, better success and greater efficiency can be obtained by combining clonidine with naltrexone to precipitate buprenorphine withdrawal than by using a dosage tapering. With a rapid clonidine/naltrexone approach, the induction on to naltrexone can be completed in as little as 1 day. Conclusions Buprenorphine can be an effective agent for opiate detoxification and transition to relapse prevention treatment using naltrexone. Ongoing work should make a once-monthly depot form of naltrexone available within a couple of years, thereby facilitating naltrexone adherence in former opiate dependent patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“RP has been disseminated for treatment of several types of substance abuse (8–12) with considerable empirical support (13–20).”
From Mindfulness-Based Relapse Prevention for Substance Use Disorders: A Pilot Efficacy Trial (2009) · cites this paper as [10]
Citations
Cites
Jasinski, D. R. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280111012 · Cited by 782
Clinical pharmacology of buprenorphine: Ceiling effects at high doses
Walsh, S. L., Preston, K. L., Stitzer, M. L., Cone, E. J., & Bigelow, G. E. (1994) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1994.71 · Cited by 773
A Controlled Trial of Buprenorphine Treatment for Opioid Dependence
Johnson, R. E. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480200058024 · Cited by 572
Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial
Ling, W., Charuvastra, C., Collins, J. F., Batki, S., Brown, L. S., Kintaudi, P., Wesson, D. R., Mcnicholas, L., Tusel, D. J., Malkerneker, U., et al. (1998) · Addiction · doi:10.1046/j.1360-0443.1998.9344753.x · Cited by 402
A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid Dependence
Ling, W. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050035005 · Cited by 366
Comparison of buprenorphine and methadone in the treatment of opioid dependence
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.7.1025 · Cited by 305
Acute administration of buprenorphine in humans: partial agonist and blockade effects.
Walsh, S. L., Preston, K. L., Bigelow, G. E., & Stitzer, M. L. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10510-7 · Cited by 283
A clinical trial of buprenorphine: Comparison with methadone in the detoxification of heroin addicts
Bickel, W. K., Stitzer, M. L., Bigelow, G. E., Liebson, I. A., Jasinski, D. R., & Johnson, R. E. (1988) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1988.13 · Cited by 260
Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans.
Bickel, W. K., Stitzer, M. L., Bigelow, G. E., Liebson, I. A., Jasinski, D. R., & Johnson, R. E. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20047-7 · Cited by 226
Effects of adding behavioral treatment to opioid detoxification with buprenorphine.
Bickel, W. K., Amass, L., Higgins, S. T., Badger, G. J., & Esch, R. A. (1997) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.65.5.803 · Cited by 199
Research works printed but not linked: 7
- Liu, 1997, Chung Kuo Yao Li Hsueh Pao, 18, 112
- Walsh, 1995, J Pharmacol Exp Ther, 274, 361
- Bickel, 1988a, J Pharmacol Exp Ther, 247, 47
- Bickel, 1997, J Consult Clin Psychol, 65, 1, 10.1037/0022-006x.65.5.803 · doi:10.1037/0022-006x.65.5.803 · Paper page
- Gowing, 2000, Cochrane Database Syst Rev, &NA;, 1
- Schuh, 1996, J Pharmacol Exp Ther, 278, 836
- Kosten, 1989, Am J Psychiatry, 146, 1349
Cited by
Mindfulness-Based Relapse Prevention for Substance Use Disorders: A Pilot Efficacy Trial
Bowen, S., Chawla, N., Collins, S. E., Witkiewitz, K., Hsu, S., Grow, J., Clifasefi, S., Garner, M., Douglass, A., Larimer, M. E., et al. (2009) · Substance Abuse · doi:10.1080/08897070903250084 · Cited by 715
Kuel, C.-H., Liu, K., Kao, C.-H., Liu, S.-Y., Wang, J., & Sung, K. C. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.3.0007 · Cited by 14
Naltrexone for Initiation and Maintenance of Opiate Abstinence
Sevarino, K. A., & Kosten, T. R. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-197-0_12 · Cited by 13
Self-citationBlondell, R. D., Smith, S. J., Servoss, T. J., DeVaul, S. K., & Simons, R. L. (2007) · Journal of Addictive Diseases · doi:10.1300/j069v26n02_02 · Cited by 11
WINSTOCK, A. R. (2012) · Elsevier eBooks · doi:10.1016/b978-0-7020-3397-1.00029-x · Cited by 4
Metadata
- Authors
- Kosten, T. R.
- Affiliations
- Yale University (US)
- Corresponding author
- Kosten, Thomas R.
- ORCID
- Kosten, Thomas R.
- Venue
- Addictive Disorders & Their Treatment
- Published
- 2003-12
- Volume
- 2
- Issue
- 4
- Pages
- 107-112
- ISSN
- 1531-5754 (ISSN-L)
- OpenAlex
- W1967577351
- Cited by
- 8
- References
- 40
- Citations by year
- 2012: 1
- FWCI
- 1.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Addictive Disorders & Their Treatment (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- buprenorphine, opioid detoxification, opioid use disorder, naltrexone, clonidine, relapse prevention, dose tapering, psychosocial interventions, methadone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Buprenorphine for Opioid Detoxification: A Brief Review. https://app.cochat.ai/papers/10.1097/00132576-200302040-00001
- The paper
- Kosten, T. R. (2003). Buprenorphine for Opioid Detoxification: A Brief Review. Addictive Disorders & Their Treatment. https://doi.org/10.1097/00132576-200302040-00001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.